185 related articles for article (PubMed ID: 34224341)
1. Giving voice to the end-user: input on multipurpose prevention technologies from the perspectives of young women in Kenya and South Africa.
Minnis AM; Krogstad E; Shapley-Quinn MK; Agot K; Ahmed K; Danielle Wagner L; van der Straten A;
Sex Reprod Health Matters; 2021 Dec; 29(1):1927477. PubMed ID: 34224341
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of end-user research to inform future multipurpose prevention technologies in sub-Saharan Africa: a scoping review.
Bhushan NL; Ridgeway K; Luecke EH; Palanee-Phillips T; Montgomery ET; Minnis AM
Front Reprod Health; 2023; 5():1156864. PubMed ID: 37325244
[TBL] [Abstract][Full Text] [Related]
3. Female and male partner perspectives on placebo Multipurpose Prevention Technologies (MPTs) used by women in the TRIO study in South Africa and Kenya.
Wagner LD; Minnis AM; Shea J; Agot K; Ahmed K; van der Straten A
PLoS One; 2022; 17(5):e0265303. PubMed ID: 35551318
[TBL] [Abstract][Full Text] [Related]
4. Young Women's Stated Preferences for Biomedical HIV Prevention: Results of a Discrete Choice Experiment in Kenya and South Africa.
Minnis AM; Browne EN; Boeri M; Agot K; van der Straten A; Ahmed K; Weinrib R; Mansfield C
J Acquir Immune Defic Syndr; 2019 Apr; 80(4):394-403. PubMed ID: 30633040
[TBL] [Abstract][Full Text] [Related]
5. Young Women's Ratings of Three Placebo Multipurpose Prevention Technologies for HIV and Pregnancy Prevention in a Randomized, Cross-Over Study in Kenya and South Africa.
Minnis AM; Roberts ST; Agot K; Weinrib R; Ahmed K; Manenzhe K; Owino F; van der Straten A;
AIDS Behav; 2018 Aug; 22(8):2662-2673. PubMed ID: 29560570
[TBL] [Abstract][Full Text] [Related]
6. End-Users' Product Preference Across Three Multipurpose Prevention Technology Delivery Forms: Baseline Results from Young Women in Kenya and South Africa.
Weinrib R; Minnis A; Agot K; Ahmed K; Owino F; Manenzhe K; Cheng H; van der Straten A
AIDS Behav; 2018 Jan; 22(1):133-145. PubMed ID: 29052018
[TBL] [Abstract][Full Text] [Related]
7. The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention.
van der Straten A; Agot K; Ahmed K; Weinrib R; Browne EN; Manenzhe K; Owino F; Schwartz J; Minnis A;
J Int AIDS Soc; 2018 Mar; 21(3):e25094. PubMed ID: 29600595
[TBL] [Abstract][Full Text] [Related]
8. Two Birds with One Stone: Health Care Providers' Perspectives about Prevention Technologies in Kenya and South Africa.
Lutnick A; Shapley-Quinn MK; Manenzhe KN; Onyango J; Agot K; Ahmed K; van der Straten A
J Int Assoc Provid AIDS Care; 2019; 18():2325958219841366. PubMed ID: 31018754
[TBL] [Abstract][Full Text] [Related]
9. Lessons from reproductive health to inform multipurpose prevention technologies: don't reinvent the wheel.
Brady M; Manning J
Antiviral Res; 2013 Dec; 100 Suppl():S25-31. PubMed ID: 24188700
[TBL] [Abstract][Full Text] [Related]
10. Preferences, educational messaging, and demand creation channels for multipurpose-prevention technologies (MPTs) among women in South Africa.
Mataboge P; Mthimkhulu N; Kutywayo A; Martin CE; Mazibuko M; Kwatsha K; Makalela N; Briedenhann E; Butler V; Bothma R; Mullick S
BMC Public Health; 2023 Oct; 23(1):2090. PubMed ID: 37880628
[TBL] [Abstract][Full Text] [Related]
11. "We are not the same": African women's view of multipurpose prevention products in the TRIO clinical study.
Shapley-Quinn MK; Manenzhe KN; Agot K; Minnis AM; van der Straten A
Int J Womens Health; 2019; 11():97-107. PubMed ID: 30799959
[TBL] [Abstract][Full Text] [Related]
12. Multipurpose prevention technologies for sexual and reproductive health: mapping global needs for introduction of new preventive products.
Schelar E; Polis CB; Essam T; Looker KJ; Bruni L; Chrisman CJ; Manning J
Contraception; 2016 Jan; 93(1):32-43. PubMed ID: 26385588
[TBL] [Abstract][Full Text] [Related]
13. Interest in multipurpose prevention technologies to prevent HIV/STIs and unintended pregnancy among young women in the United States.
Hynes JS; Sales JM; Sheth AN; Lathrop E; Haddad LB
Contraception; 2018 Mar; 97(3):277-284. PubMed ID: 29055782
[TBL] [Abstract][Full Text] [Related]
14. The cost-effectiveness of multi-purpose HIV and pregnancy prevention technologies in South Africa.
Quaife M; Terris-Prestholt F; Eakle R; Cabrera Escobar MA; Kilbourne-Brook M; Mvundura M; Meyer-Rath G; Delany-Moretlwe S; Vickerman P
J Int AIDS Soc; 2018 Mar; 21(3):. PubMed ID: 29537654
[TBL] [Abstract][Full Text] [Related]
15. Insights for Implementation Science From 2 Multiphased Studies With End-Users of Potential Multipurpose Prevention Technology and HIV Prevention Products.
Minnis AM; Montgomery ET; Napierala S; Browne EN; van der Straten A
J Acquir Immune Defic Syndr; 2019 Dec; 82 Suppl 3():S222-S229. PubMed ID: 31764258
[TBL] [Abstract][Full Text] [Related]
16. Making the Case for Joint Decision-Making in Future Multipurpose Prevention Technology (MPT) Choice: Qualitative Findings on MPT Attribute Preferences from the CUPID Study (MTN-045).
Bhushan NL; Musara P; Hartmann M; Stoner MCD; Shah SR; Nabukeera J; Rukundo I; Mutero P; Lewis MA; Piper J; Shapley-Quinn MK; Etima J; Minnis AM
J Int AIDS Soc; 2022 Oct; 25(10):e26024. PubMed ID: 36254362
[TBL] [Abstract][Full Text] [Related]
17. Advances in long-acting injectables, implants, and vaginal rings for contraception and HIV prevention.
Krovi SA; Johnson LM; Luecke E; Achilles SL; van der Straten A
Adv Drug Deliv Rev; 2021 Sep; 176():113849. PubMed ID: 34186143
[TBL] [Abstract][Full Text] [Related]
18. Optimizing the pipeline of multipurpose prevention technologies: opportunities across women's reproductive lifespans.
Bershteyn A; Resar D; Kim HY; Platais I; Mullick S
Front Reprod Health; 2023; 5():1169110. PubMed ID: 37325241
[TBL] [Abstract][Full Text] [Related]
19. Exploring user and stakeholder perspectives from South Africa and Uganda to refine microarray patch development for HIV PrEP delivery and as a multipurpose prevention technology.
Ismail A; Magni S; Katahoire A; Ayebare F; Siu G; Semitala F; Kyambadde P; Friedland B; Jarrahian C; Kilbourne-Brook M
PLoS One; 2023; 18(8):e0290568. PubMed ID: 37651432
[TBL] [Abstract][Full Text] [Related]
20. Engaging study participants in interpreting results: lessons from the TRIO study in Kenya and South Africa.
Agot K; Minnis AM; Manenzhe K; Browne EN; Ahmed K; Okello T; van der Straten A
Int J Womens Health; 2019; 11():395-403. PubMed ID: 31372060
[No Abstract] [Full Text] [Related]
[Next] [New Search]
